Sabra Health Care REIT, Inc. (SBRA) stock
SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3059% above fair value
$20.35−0.09 (-0.44%)
Close on Nov 16, 2026Market cap $5.20BP/E 78.3Yield 5.90%
Sabra Health Care REIT profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Sabra Health Care REIT's profit margin for the twelve months ending Jun 30, 2026 was 7.6%. For fiscal 2025 it was 20.1%, against 18.0% the year before. The highest annual figure on record is 44.8% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.1% | +2.1 |
| FY2024 | Dec 31, 2024 | 18.0% | +15.9 |
| FY2023 | Dec 31, 2023 | 2.1% | +14.5 |
| FY2022 | Dec 31, 2022 | -12.4% | +7.5 |
| FY2021 | Dec 31, 2021 | -19.9% | −43.0 |
| FY2020 | Dec 31, 2020 | 23.1% | +12.7 |
| FY2019 | Dec 31, 2019 | 10.4% | −34.3 |
| FY2018 | Dec 31, 2018 | 44.8% | +6.0 |
| FY2017 | Dec 31, 2017 | 38.8% | +11.8 |
| FY2016 | Dec 31, 2016 | 27.0% | −6.3 |
| FY2015 | Dec 31, 2015 | 33.2% | +7.7 |
| FY2014 | Dec 31, 2014 | 25.6% | +0.6 |
| FY2013 | Dec 31, 2013 | 25.0% | +6.1 |
| FY2012 | Dec 31, 2012 | 18.9% | +3.7 |
| FY2011 | Dec 31, 2011 | 15.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -10.7% | −45.3 |
| Q1 FY2026 | Mar 31, 2026 | 18.4% | −3.5 |
| Q4 FY2025 | Dec 31, 2025 | 12.8% | −12.8 |
| Q3 FY2025 | Sep 30, 2025 | 11.9% | −4.9 |
| Q2 FY2025 | Jun 30, 2025 | 34.7% | +21.0 |
| Q1 FY2025 | Mar 31, 2025 | 22.0% | +6.2 |
| Q4 FY2024 | Dec 31, 2024 | 25.6% | +15.1 |
| Q3 FY2024 | Sep 30, 2024 | 16.7% | +26.1 |
| Q2 FY2024 | Jun 30, 2024 | 13.6% | +0.5 |
| Q1 FY2024 | Mar 31, 2024 | 15.7% | +21.6 |
| Q4 FY2023 | Dec 31, 2023 | 10.5% | +62.0 |
| Q3 FY2023 | Sep 30, 2023 | -9.3% | +26.2 |
| Q2 FY2023 | Jun 30, 2023 | 13.1% | +2.4 |
| Q1 FY2023 | Mar 31, 2023 | -5.9% | −30.8 |
| Q4 FY2022 | Dec 31, 2022 | -51.5% | −33.5 |
| Q3 FY2022 | Sep 30, 2022 | -35.6% | −43.5 |
| Q2 FY2022 | Jun 30, 2022 | 10.8% | +97.5 |
| Q1 FY2022 | Mar 31, 2022 | 24.9% | +2.9 |
| Q4 FY2021 | Dec 31, 2021 | -18.0% | −42.4 |
| Q3 FY2021 | Sep 30, 2021 | 8.0% | −17.5 |
| Q2 FY2021 | Jun 30, 2021 | -86.7% | −105.9 |
| Q1 FY2021 | Mar 31, 2021 | 22.0% | −3.6 |
| Q4 FY2020 | Dec 31, 2020 | 24.4% | +8.9 |
| Q3 FY2020 | Sep 30, 2020 | 25.5% | −12.7 |
| Q2 FY2020 | Jun 30, 2020 | 19.2% | +76.1 |
| Q4 FY2019 | Dec 31, 2019 | 25.5% | +39.4 |
| Q3 FY2019 | Sep 30, 2019 | 15.5% | −7.7 |
| Q2 FY2019 | Jun 30, 2019 | 38.1% | −82.6 |
| Q1 FY2019 | Mar 31, 2019 | -56.8% | −94.4 |
| Q4 FY2018 | Dec 31, 2018 | -13.9% | −75.4 |
| Q3 FY2018 | Sep 30, 2018 | 23.2% | +9.7 |
| Q2 FY2018 | Jun 30, 2018 | 120.7% | +89.0 |
| Q1 FY2018 | Mar 31, 2018 | 37.6% | +7.6 |
| Q4 FY2017 | Dec 31, 2017 | 61.5% | +24.0 |
| Q3 FY2017 | Sep 30, 2017 | 13.5% | −27.4 |
| Q2 FY2017 | Jun 30, 2017 | 31.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 30.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 37.5% | – |
| Q3 FY2016 | Sep 30, 2016 | 40.9% | – |
See a number that looks wrong?